A key milestone and partnership for the clinical implementation of upright radiotherapy has been announced. RaySearch Laboratories AB (publ) and Leo Cancer Care in Horley, Great Britain, are joining forces to offer a streamlined treatment planning solution for upright treatments

September 2, 2022 — A key milestone and partnership for the clinical implementation of upright radiotherapy has been announced. RaySearch Laboratories AB and Leo Cancer Care in Horley, Great Britain, are joining forces to offer a streamlined treatment planning solution for upright treatments.   

The partnership will see the integration of RayStation, the comprehensive treatment planning system offered by RaySearch, with Leo Cancer Care’s upright radiation therapy technology. Enabling clinics adopting upright radiotherapy to now complete an end-to-end clinical workflow and providing the ability to plan external beam treatments, as well as leverage several features including adaptive therapy capabilities and multi-criteria optimization to provide accurate treatment plans. Also, RayCare, the next generation oncology information system offered by RaySearch, will be integrated with Leo Cancer Care’s treatment technology. Together, the combination of RayCare, RayStation and Leo Cancer Care’s solutions will provide a safe, efficient, and fully integrated platform for upright radiation treatments. 

Priding itself on being “the more human way to deliver radiation therapy”, Leo Cancer Care’s solutions feature an upright patient positioning system and upright imaging technologies that are placed in front of a fixed radiation beam. The technology seeks to improve patient and clinician experience, which will be further solidified by the addition of the well adopted treatment planning solution from RaySearch.   

Leo Cancer Care has completed the build of their first ever upright dual-energy, fan-beam CT scanner and are now acquiring images. Using these early images, the team at RaySearch have developed the capabilities within RayStation to plan upright treatments, even using images that are taken on complimentary imaging systems in the supine orientation. 

Johan Löf, founder and CEO, RaySearch, says: “We have been following the work of Leo Cancer Care for quite some time, and we find that their approach to radiation therapy is a smart, effective, and potentially revolutionizing development. Like so many of the other contributions to the field that bear the signature of Rock Mackie, the idea of upright radiation treatment is well thought out and makes a lot of sense for a very wide range of indications. I am happy that we have now taken the step to formalize the relationship with Leo Cancer Care and I believe our technologies have great potential together.” 

This collaboration will enable treatment planning for both of Leo Cancer Care’s solutions for particle and photon therapy treatments. This partnership brings together the expertise needed to create the best possible solution for treatment planning in the upright orientation, Leo Cancer Care are experts in upright radiation therapy and RaySearch are the world-leading experts in treatment planning. 

Stephen Towe CEO and Co-founder of Leo Cancer Care says: “We are delighted to be announcing this partnership with RaySearch as we make this huge leap towards a clinical role out of the Leo technology. RayStation has had a huge impact on the world of treatment planning, and we are excited to be able to offer this new integrated solution to our partners across the globe.” 

For more information: www.raysearchlabs.com 

Find more content on ASTRO22 


Related Content

News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
Subscribe Now